The United States has launched lenacapavir (LEN), the new long-acting HIV prevention drug, in Zimbabwe, with plans to support thousands op poeple.
Read Article
Zimbabwe has taken a decisive step forward in strengthening its national health system with the official commissioning of Nucleic Acid Testing (NAT) for blood screening at the National Blood Service Zimbabwe (NBSZ) headquarters in Harare.
Read Article
Zimbabwe's health authorities on Thursday (19 February) began administering the long-acting injectable HIV prevention drug lenacapavir, making the country one of the first globally to roll it out as the southern African nation seeks to curb new infections. Health Minister Douglas Mombeshora said the programme, funded by the US and the Global Fund, would initially target more than 46,000 people at high risk of contracting HIV across 24 sites nationwide.
Read Article
As the African Vaccination Week (24-30 April 2025) unfolds, the First Lady of Zimbabwe, H.E. Dr. Auxillia Mnangagwa, has issued a powerful call to action. Her message is clear: no one and no area should be left behind in the quest for universal vaccination coverage.
Read ArticleCondom distribution, PrEP, and behavior change communication reaching millions across all provinces.
Learn MoreExpanding access to antiretroviral therapy across all provinces with 92% coverage achieved.
Learn MoreSocial Contracting uses domestic and public resources to support Civil Society Organizations (CSOs) that are better positioned to meet national health priorities
Learn MoreMonitoring the epidemic through cutting-edge research to inform evidence-based policy decisions.
Learn More
Highlights from the National AIDS Council Annual General Meeting with key stakeholders.
Blood Bank and Renal Unit support for improved healthcare services.
Commemorations with community engagement and awareness campaigns across Zimbabwe.